Clinical Trials Browser

Phase 2/3 × Prostatic Neoplasms × bicalutamide × Clear all

NCT03348670 2025-08-17

Drugs-SNPs

Phase 2/3 Active not recruiting

Neoplasms, Prostatic Neoplasms

NCT00421694 2007-10-08

Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide

Phase 2/3 Completed

Prostatic Neoplasms